1
|
Young E, Pastor S, Rajagopalan R, McCaffrey J, Sibert J, Mak ACY, Kwok PY, Riethman H, Xiao M. High-throughput single-molecule mapping links subtelomeric variants and long-range haplotypes with specific telomeres. Nucleic Acids Res 2017; 45:e73. [PMID: 28180280 PMCID: PMC5605236 DOI: 10.1093/nar/gkx017] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2016] [Accepted: 02/07/2017] [Indexed: 01/22/2023] Open
Abstract
Accurate maps and DNA sequences for human subtelomere regions, along with detailed knowledge of subtelomere variation and long-range telomere-terminal haplotypes in individuals, are critical for understanding telomere function and its roles in human biology. Here, we use a highly automated whole genome mapping technology in nano-channel arrays to analyze large terminal human chromosome segments extending from chromosome-specific subtelomere sequences through subtelomeric repeat regions to terminal (TTAGGG)n repeat tracts. We establish detailed maps for subtelomere gap regions in the human reference sequence, detect many new large subtelomeric variants and demonstrate the feasibility of long-range haplotyping through segmentally duplicated subtelomere regions. These features make the method a uniquely valuable new tool for improving the quality of genome assemblies in complex DNA regions. Based on single molecule mapping of telomere-terminal DNA fragments, we provide proof of principle for a novel method to estimate telomere lengths linked to distinguishable telomeric haplotypes; this single-telomere genotyping method may ultimately enable delineation of human cis elements involved in telomere length regulation.
Collapse
Affiliation(s)
- Eleanor Young
- Drexel University, School of Biomedical Engineering, Philadelphia, PA, 19104 USA
| | - Steven Pastor
- Drexel University, School of Biomedical Engineering, Philadelphia, PA, 19104 USA
| | | | - Jennifer McCaffrey
- Drexel University, School of Biomedical Engineering, Philadelphia, PA, 19104 USA
| | - Justin Sibert
- Drexel University, School of Biomedical Engineering, Philadelphia, PA, 19104 USA
| | - Angel C Y Mak
- Cardiovascular Research Institute, University of California, San Francisco, CA, 94158 USA
| | - Pui-Yan Kwok
- Cardiovascular Research Institute, University of California, San Francisco, CA, 94158 USA
| | - Harold Riethman
- Old Dominion University, Medical Diagnostic and Translational Sciences, Norfolk, VA, 23529 USA
| | - Ming Xiao
- Drexel University, School of Biomedical Engineering, Philadelphia, PA, 19104 USA.,Institute of Molecular Medicine and Infectious Disease, School of Medicine, Drexel University, Philadelphia, PA, 19102 USA
| |
Collapse
|
7
|
Knight SJL, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, Regan R, Brenan M, Nicod A, Lawrie NM, Cardy DLN, Nguyen H, Hudson TJ, Riethman HC, Ledbetter DH, Flint J. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet 2000; 67:320-32. [PMID: 10869233 PMCID: PMC1287181 DOI: 10.1086/302998] [Citation(s) in RCA: 214] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2000] [Accepted: 05/22/2000] [Indexed: 11/04/2022] Open
Abstract
Telomere-specific clones are a valuable resource for the characterization of chromosomal rearrangements. We previously reported a first-generation set of human telomere probes consisting of 34 genomic clones, which were a known distance from the end of the chromosome ( approximately 300 kb), and 7 clones corresponding to the most distal markers on the integrated genetic/physical map (1p, 5p, 6p, 9p, 12p, 15q, and 20q). Subsequently, this resource has been optimized and completed: the size of the genomic clones has been expanded to a target size of 100-200 kb, which is optimal for use in genome-scanning methodologies, and additional probes for the remaining seven telomeres have been identified. For each clone we give an associated mapped sequence-tagged site and provide distances from the telomere estimated using a combination of fiberFISH, interphase FISH, sequence analysis, and radiation-hybrid mapping. This updated set of telomeric clones is an invaluable resource for clinical diagnosis and represents an important contribution to genetic and physical mapping efforts aimed at telomeric regions.
Collapse
Affiliation(s)
- Samantha J. L. Knight
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Christa M. Lese
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Kathrin S. Precht
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Julie Kuc
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Yi Ning
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Sarah Lucas
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Regina Regan
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Mary Brenan
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Alison Nicod
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - N. Martin Lawrie
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Donald L. N. Cardy
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Huy Nguyen
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Thomas J. Hudson
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Harold C. Riethman
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - David H. Ledbetter
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| | - Jonathan Flint
- Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Human Genetics, The University of Chicago, Chicago; Gene-Care Medical Genetics Center and George Washington University, Washington, DC; Cytocell Ltd., Adderbury, Oxfordshire, United Kingdom; Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, MA; Montreal Genome Centre, McGill University Health Centre, Montreal; and The Wistar Institute, Philadelphia
| |
Collapse
|